Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Gustave Roussy among the top 5 best cancer hospitals in the world
Gustave Roussy is in 5th position worldwide and 1st hospital outside of the United States, according to the World’s Best Specialized Hospitals 2021 ranking by Newsweek magazine
Published on
According to the World’s Best Specialized Hospitals 2021 ranking by Newsweek magazine, Gustave Roussy is in 5th position worldwide and 1st hospital outside of the United States. This ranking emphasizes the international recognition for excellence in care and powerful research performed by the Institute. It also means that patients, whose decision to choose the right hospital is determined mainly by the hospital’s reputation, can be confident and receive in France both the best care and the most effective clinical research.
"We are proud to be one of the world's top 5 cancer centers along with four American giants. This ranking is an important recognition of our savoir-faire and team expertise. Both our medical staff and scientists play an important part in making French healthcare one of the best in the world. Gustave Roussy has the ability to meet all the challenges of the 21st century: to detect, to study, to fight against, to care for and to overcome cancer" explains Professor Jean-Charles Soria, CEO of Gustave Roussy.
This new ranking reinforces Gustave Roussy's international reputation. Honored every year in the Clarivate ranking, with 10 of its experts featuring in the 2019 list of the world's most "Highly cited researchers". Gustave Roussy's physician-scientists are also regularly awarded prizes at international congresses by learned societies or major research organizations or foundations. Knowledge production is intensive, with 1,800 international publications, including more than 60 in highly cited papers (journal impact factor greater than 30).
Today, the Institute is a key player in the world for early trials, immunotherapy and precision medicine clinical trials. Nearly a quarter of Gustave Roussy's patients are part of a clinical study.
Today, by developing its new institutional strategic plan for the next ten years, Gustave Roussy is all geared up for the fight against cancer and the growing complexity of the disease, all for the benefit of their patients.
More about
Last news
-
Gustave Roussy Meets His Audience
As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.
-
Mens November: Take care of your jewelry its precious!
November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases.
-
Nuclear medicine: DART, a pioneering platform for the development of alpha therapy
Developed through a partnership between Gustave Roussy and the Paris-Saclay Cancer Cluster, the DART project aims to provide industry partners with a centre of excellence spanning preclinical, clinical and translational research to support the development of alpha therapy. This innovative nuclear medicine approach can destroy cancer cells more powerfully than standard approaches while reducing damage to surrounding healthy cells.
-
Gustave Roussy at the ESMO 2026 Congress
The European Society for Medical Oncology (ESMO) is holding its annual congress from 23 to 27 October in Madrid, Spain. This major international event provides oncologists and researchers from around the world with an opportunity to present the latest findings from clinical studies aimed at improving cancer care and deepening our understanding of the disease. Once again, this year, physicians and researchers from Gustave Roussy have contributed to several dozen studies that will be presented during the five-day congress.
